These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20361903)

  • 1. Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients.
    Procyshyn RM; Honer WG; Wu TK; Ko RW; McIsaac SA; Young AH; Johnson JL; Barr AM
    J Clin Psychiatry; 2010 May; 71(5):566-73. PubMed ID: 20361903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.
    Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L
    Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of antipsychotic utilization in a tertiary care psychiatric institution.
    Procyshyn RM; Thompson B
    Pharmacopsychiatry; 2004 Jan; 37(1):12-7. PubMed ID: 14750043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder.
    Elie D; Poirier M; Chianetta J; Durand M; Grégoire C; Grignon S
    J Psychopharmacol; 2010 Jul; 24(7):1037-44. PubMed ID: 19164494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social and clinical descriptors of antipsychotic prescription.
    Piccinni C; Piazza A; Poluzzi E; Tarricone I; Koci A; Berardi D; Fioritti A; de Ponti F
    Int J Psychiatry Med; 2015; 49(1):45-62. PubMed ID: 25838320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic polypharmacy among patients admitted to a geriatric psychiatry unit.
    Dolder CR; McKinsey J
    J Psychiatr Pract; 2011 Sep; 17(5):368-74. PubMed ID: 21926533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, correlates, and disease patterns of antipsychotic use in Taiwan.
    Chien IC; Hsu JH; Bih SH; Lin CH; Chou YJ; Lee CH; Chou P
    Psychiatry Clin Neurosci; 2008 Dec; 62(6):677-84. PubMed ID: 19068004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of polypharmacy with second generation antipsychotics in patients with severe and persistent mental illness.
    Megna JL; Kunwar AR; Mahlotra K; Sauro MD; Devitt PJ; Rashid A
    J Psychiatr Pract; 2007 Mar; 13(2):129-37. PubMed ID: 17414692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic polypharmacy in patients with schizophrenia in a brief hospitalization unit.
    Lerma-Carrillo I; de Pablo Brühlmann S; del Pozo ML; Pascual-Pinazo F; Molina JD; Baca-García E
    Clin Neuropharmacol; 2008; 31(6):319-32. PubMed ID: 19050409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and social determinants of antipsychotic polypharmacy for Chinese patients with schizophrenia.
    Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
    Pharmacopsychiatry; 2007 Mar; 40(2):47-52. PubMed ID: 17447172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and clinical changes during hospitalization in bipolar and psychotic disorder patients with versus without substance-use disorders.
    Vincenti A; Ventriglio A; Baldessarini RJ; Talamo A; Fitzmaurice G; Centorrino F
    Pharmacopsychiatry; 2010 Aug; 43(6):225-32. PubMed ID: 20652858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic polypharmacy in outpatients at Birch Hill Hospital: incidence and adherence to guidelines.
    Ranceva N; Ashraf W; Odelola D
    J Clin Pharmacol; 2010 Jun; 50(6):699-704. PubMed ID: 20056801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excessive dosing and polypharmacy of antipsychotics caused by pro re nata in agitated patients with schizophrenia.
    Fujita J; Nishida A; Sakata M; Noda T; Ito H
    Psychiatry Clin Neurosci; 2013 Jul; 67(5):345-51. PubMed ID: 23711166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
    Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor agreement amongst psychiatrists assessing rationality in five cases of psychiatric polypharmacy.
    Lochmann van Bennekom MW; Gijsman HJ; de Beurs E; Zitman FG
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1069-71. PubMed ID: 18343550
    [No Abstract]   [Full Text] [Related]  

  • 19. Conventional antipsychotic prescription in unipolar depression, II: withdrawing conventional antipsychotics in unipolar, nonpsychotic patients.
    Mortimer AM; Martin M; Wheeler Vega JA; Tyson PJ
    J Clin Psychiatry; 2003 Jun; 64(6):668-72; quiz 738-9. PubMed ID: 12823081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Explicit versus implicit review to explore combination antipsychotic prescribing.
    Wheeler A
    J Eval Clin Pract; 2009 Aug; 15(4):685-91. PubMed ID: 19674220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.